This inventor holds 2 USPTO granted patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2013
Title: The Innovative Contributions of Dionisois Rentzeperis
Introduction
Dionisois Rentzeperis is a notable inventor based in Downingtown, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various medical conditions. With a total of 2 patents, his work has the potential to impact numerous patients suffering from chronic diseases.
Latest Patents
Rentzeperis's latest patents focus on "Substituted phenoxy thiazolidinediones as estrogen related receptor-α modulators." These inventions relate to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates, and derivatives. The applications of these compounds are extensive, addressing conditions such as ankylosing spondylitis, atherosclerosis, various forms of arthritis, breast cancer, cardiovascular disorders, and metabolic syndrome, among others. His innovative approach aims to provide new treatment options for diseases that are often challenging to manage.
Career Highlights
Dionisois Rentzeperis is currently employed at Janssen Pharmaceutica NV, a company renowned for its commitment to advancing healthcare through innovative solutions. His work at Janssen has allowed him to focus on developing groundbreaking therapies that can improve patient outcomes.
Collaborations
Throughout his career, Rentzeperis has collaborated with esteemed colleagues, including Michael Gaul and Alexander Y Kim. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful medical solutions.
Conclusion
Dionisois Rentzeperis exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research and development in addressing complex health issues. His work continues to pave the way for advancements in medical treatments that can benefit countless individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
